RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RTTR

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/05/15	06 : 11	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/15	03 : 13	GlobeNewswire Inc.	Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/14	22 : 50	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/11	21 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/11	21 : 02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/11	21 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/09	05 : 06	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/06	22 : 23	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/06	22 : 15	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each o...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/05	19 : 14	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/02	06 : 35	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/02	06 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/02	06 : 31	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/05/02	06 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/28	20 : 36	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/28	20 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/25	06 : 21	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/24	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/21	19 : 11	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/21	19 : 10	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/17	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/17	05 : 06	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/17	03 : 07	GlobeNewswire Inc.	Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/10	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/09	22 : 30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/07	06 : 18	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/06	19 : 16	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/01	06 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/01	06 : 28	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2020/04/01	06 : 27	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019	NASDAQ:RTTR	Ritter Pharmaceuticals Inc